Theranos whistleblower Tyler Shultz warned that the current AI boom is "a great opportunity to go deceive people", in an interview with The San Francisco Standard published as a documentary about Elizabeth Holmes gains wide attention. Shultz, whose first job out of college was at Theranos, helped expose the company's inaccurate blood-testing devices, which reached Walgreens stores and returned faulty results to patients.
Theranos reached a valuation of around $10 billion even though its technology never worked at scale, with most tests outsourced to third-party machines, and Holmes is now in federal prison. The film "You Can See Everything", directed by Nathan Fielder and Lance Oppenheim, covers her final weeks before prison and deliberately avoids casting her as either master manipulator or victim, becoming one of the highest-grossing documentaries.
Shultz's warning lands as investors pour record sums into AI companies whose claims are hard for outsiders to verify, making due diligence and whistleblower protections the central safeguards against a repeat of the Theranos pattern. His point is less about Holmes than about the incentives that let confident founders outrun the evidence for years.

Theranos whistleblower Tyler Shultz warned that the current AI boom is "a great opportunity to go deceive people", in an interview with The San Francisco Standard published as a documentary about Elizabeth Holmes gains wide attention. Shultz, whose first job out of college was at Theranos, helped expose the company's inaccurate blood-testing devices, which reached Walgreens stores and returned faulty results to patients.

Theranos reached a valuation of around $10 billion even though its technology never worked at scale, with most tests outsourced to third-party machines, and Holmes is now in federal prison. The film "You Can See Everything", directed by Nathan Fielder and Lance Oppenheim, covers her final weeks before prison and deliberately avoids casting her as either master manipulator or victim, becoming one of the highest-grossing documentaries.

Shultz's warning lands as investors pour record sums into AI companies whose claims are hard for outsiders to verify, making due diligence and whistleblower protections the central safeguards against a repeat of the Theranos pattern. His point is less about Holmes than about the incentives that let confident founders outrun the evidence for years.

πŸ“° Source: News Source
techcrunch.com β†—
Was this article useful?